Lukas Bastian Otto: Bow Hunter’s Syndrome as a Hidden Cause of Cerebellar Infarction
Lukas Bastian Otto, Neurology Research Resident at University Hospital Zurich, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in BMJ Case Reports, adding:
“Who knew that asking a patient to ‘look left’ could change the entire diagnosis?
Excited to share our latest BMJ Case Reports describing a rare presentation of Bow Hunter’s Syndrome causing recurrent embolic cerebellar infarctions from the non-dominant vertebral artery.
The case highlights the importance of thinking beyond static imaging—sometimes the diagnosis only becomes apparent with dynamic vascular assessment.
Together with Hakim Baazaoui and our supervisor Susanne Wegener, I had the pleasure of working on this case report.
A big thank you to our collaborators from Neurology, Ferdinand Otto, Neuroradiology, Miklos Krepuska, and Neurosurgery Menno Germans at the University Hospital Zurich—this case is a great example of what multidisciplinary teamwork can achieve.”
Title: Recurrent embolic cerebellar infarction due to bow hunter’s syndrome of the non-dominant vertebral artery
Authors: Hakim Baazaoui, Lukas Bastian Otto, Ferdinand Otto, Miklos Krepuska, Menno Germans, Susanne Wegener

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI